Literature DB >> 9175829

Tuning antigen receptor signaling by CD22: integrating cues from antigens and the microenvironment.

J G Cyster1, C C Goodnow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9175829     DOI： 10.1016/s1074-7613(00)80339-8

Source DB:  PubMed          Journal:  Immunity        ISSN： 1074-7613            Impact factor:   31.745


× No keyword cloud information.
  37 in total

1.  Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor.

Authors:  J Munday; S Kerr; J Ni; A L Cornish; J Q Zhang; G Nicoll; H Floyd; M G Mattei; P Moore; D Liu; P R Crocker
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

Review 2.  Siglecs in the immune system.

Authors:  P R Crocker; A Varki
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

3.  Nanoscale organization and dynamics of the siglec CD22 cooperate with the cytoskeleton in restraining BCR signalling.

Authors:  Francesca Gasparrini; Christoph Feest; Andreas Bruckbauer; Pieta K Mattila; Jennifer Müller; Lars Nitschke; Dennis Bray; Facundo D Batista
Journal:  EMBO J       Date:  2015-12-15       Impact factor: 11.598

Review 4.  Rethinking mechanisms of autoimmune pathogenesis.

Authors:  Shiv Pillai
Journal:  J Autoimmun       Date:  2013-06-25       Impact factor: 7.094

Review 5.  Intravenous immunoglobulin-mediated immunosuppression and the development of an IVIG substitute.

Authors:  Miglena G Prabagar; Hyeong-jwa Choi; Jin-Yeon Park; Sohee Loh; Young-Sun Kang
Journal:  Clin Exp Med       Date:  2013-09-01       Impact factor: 3.984

Review 6.  Siglecs as sensors of self in innate and adaptive immune responses.

Authors:  James C Paulson; Matthew S Macauley; Norihito Kawasaki
Journal:  Ann N Y Acad Sci       Date:  2012-01-30       Impact factor: 5.691

7.  CD22 expression mediates the regulatory functions of peritoneal B-1a cells during the remission phase of contact hypersensitivity reactions.

Authors:  Hiroko Nakashima; Yasuhito Hamaguchi; Rei Watanabe; Nobuko Ishiura; Yoshihiro Kuwano; Hitoshi Okochi; Yoshimasa Takahashi; Kunihiko Tamaki; Shinichi Sato; Thomas F Tedder; Manabu Fujimoto
Journal:  J Immunol       Date:  2010-03-24       Impact factor: 5.422

8.  ST6Gal-I restrains CD22-dependent antigen receptor endocytosis and Shp-1 recruitment in normal and pathogenic immune signaling.

Authors:  Prabhjit K Grewal; Mark Boton; Kevin Ramirez; Brian E Collins; Akira Saito; Ryan S Green; Kazuaki Ohtsubo; Daniel Chui; Jamey D Marth
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

Review 9.  Advances in targeted therapy for malignant lymphoma.

Authors:  Li Wang; Wei Qin; Yu-Jia Huo; Xiao Li; Qing Shi; John E J Rasko; Anne Janin; Wei-Li Zhao
Journal:  Signal Transduct Target Ther       Date:  2020-03-06

10.  Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact.

Authors:  Brian E Collins; Ola Blixt; Alexis R DeSieno; Nicolai Bovin; Jamey D Marth; James C Paulson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.